BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
수요일, 9월 30

Tenet Healthcare Corp

THCNYSE
Trade with Public
Trade with Public
$257.43
-0.17-0.07%
마지막 업데이트: Sep 30, 11:17 AM
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Tenet Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tenet Healthcare (THC).

Price Target Range — 9 Quarters

Analyst Consensus — 20 Analysts

18Buy
2Hold
Consensus RatingOverweight# Analysts20Avg. Consensus PT$253Upside to Avg. PT-1.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →
DateFirmAnalystActionRating ChangePrice Target
Sep 23, 2026BMO CapitalSean DodgeInitiateMarket Perform$265
Sep 18, 2026Leerink PartnersWhit MayoMaintainedOutperform$309
More with Benzinga EdgeGet Access

Analyst Ratings News

Junk Bond Yields Are Back Above 15%: 10 Stocks In The Pressure Zone

Junk bond yields surpassed 15%, the highest since 2022. These 10 stocks with bonds in XCCC carry $97 billion of debt as higher rates bite.
Piero Cingari

PRO
BMO Capital Initiates Coverage On Tenet Healthcare with Market Perform Rating, Announces Price Target of $265

BMO Capital analyst Sean Dodge initiates coverage on Tenet Healthcare (NYSE:THC) with a Market Perform rating and announces Price Target of $265.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $281

Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $231 to $281.
Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $290

Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $270 to $290.
Benzinga Newsdesk

Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on top names. For a complete view, see analyst ratings page. See how others view these stocks.
Avi Kapoor

PRO
Baird Maintains Neutral on Tenet Healthcare, Raises Price Target to $280

Baird analyst Michael Ha maintains Tenet Healthcare (NYSE:THC) with a Neutral and raises the price target from $210 to $280.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved